menu ☰
menu ˟

Alimera predicts potential $2 billion global market for Iluvien brand

26 Mar 2015
The Iluvien intravitreal implant will satisfy an unmet need among patients with diabetic macular edema and create sizeable new markets, Alimera Sciences officials said during a company-sponsored webcast.Iluvien (fluocinolone acetonide intravitreal im...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.